Age, Biography and Wiki

Venki Ramakrishnan (Venkatraman Ramakrishnan) was born on 5 April, 1952 in Chidambaram, Madras State (now Tamil Nadu), India, is a British-American structural biologist (born 1952). Discover Venki Ramakrishnan's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 71 years old?

Popular As Venkatraman Ramakrishnan
Occupation N/A
Age 71 years old
Zodiac Sign Aries
Born 5 April, 1952
Birthday 5 April
Birthplace Chidambaram, Madras State (now Tamil Nadu), India
Nationality United Kingdom

We recommend you to check the complete list of Famous People born on 5 April. He is a member of famous with the age 71 years old group.

Venki Ramakrishnan Height, Weight & Measurements

At 71 years old, Venki Ramakrishnan height not available right now. We will update Venki Ramakrishnan's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Venki Ramakrishnan's Wife?

His wife is Vera Rosenberry (m. 1975)

Family
Parents Not Available
Wife Vera Rosenberry (m. 1975)
Sibling Not Available
Children 1

Venki Ramakrishnan Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Venki Ramakrishnan worth at the age of 71 years old? Venki Ramakrishnan’s income source is mostly from being a successful . He is from United Kingdom. We have estimated Venki Ramakrishnan's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Venki Ramakrishnan Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Venki Ramakrishnan Wikipedia
Imdb

Timeline

1952

Venkatraman "Venki" Ramakrishnan (born 1952) is a British-American structural biologist.

Ramakrishnan was born in 1952 in Chidambaram in Cuddalore district of Tamil Nadu, India.

His parents, Prof. C. V. Ramakrishnan and Prof. Rajalakshmi Ramakrishnan were both scientists, and his father was head of the department of biochemistry at the Maharaja Sayajirao University of Baroda.

At the time of his birth, Ramakrishnan's father was away from India doing postdoctoral research with David E. Green at the University of Wisconsin–Madison in the US.

1959

Ramakrishnan's mother obtained a PhD in psychology from McGill University in 1959, completing it in only 18 months, and was mentored, among others, by Donald O. Hebb.

Ramakrishnan has one sibling, his younger sister Lalita Ramakrishnan, who is professor of immunology and infectious diseases at the department of medicine, University of Cambridge, and a member of the National Academy of Sciences.

1960

Ramakrishnan moved to Vadodara (previously also known as Baroda) in Gujarat at the age of three, where he had his entire schooling at the Convent of Jesus and Mary, except for a year and a half (1960–61) which he and his family spent in Adelaide, Australia.

1971

Following his pre-science at the Maharaja Sayajirao University of Baroda, he did his undergraduate studies in the same university on a National Science Talent Scholarship, graduating with a Bachelor of Science degree in physics in 1971.

At the time, the physics course at Baroda was new, and based in part on the Berkeley Physics Course and The Feynman Lectures on Physics.

1976

Immediately after graduation he moved to the US, where he obtained his Doctor of Philosophy degree in physics from Ohio University in 1976 for research into the ferroelectric phase transition of potassium dihydrogen phosphate (KDP) supervised by Tomoyasu Tanaka.

Then he spent two years studying biology as a graduate student at the University of California, San Diego while making a transition from theoretical physics to biology.

Ramakrishnan began work on ribosomes as a postdoctoral fellow with Peter Moore at Yale University.

After his post-doctoral fellowship, he initially could not find a faculty position even though he had applied to about 50 universities in the United States.

1983

He continued to work on ribosomes from 1983 to 1995 as a staff scientist at Brookhaven National Laboratory.

1995

In 1995, he moved to the University of Utah as a professor of biochemistry, and in 1999, he moved to his current position at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England, where he had also been a sabbatical visitor during 1991–92 on a Guggenheim Fellowship.

1999

Since 1999, he has worked as a group leader at the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) on the Cambridge Biomedical Campus, UK and is a Fellow of Trinity College, Cambridge.

In 1999, Ramakrishnan's laboratory published a 5.5 angstrom resolution structure of the 30S subunit.

The following year, his laboratory determined the complete molecular structure of the 30S subunit of the ribosome and its complexes with several antibiotics.

This was followed by studies that provided structural insights into the mechanism that ensures the fidelity of protein biosynthesis.

2002

Ramakrishnan was elected a Member of the European Molecular Biology Organization in 2002, a Fellow of the Royal Society (FRS) in 2003, and a Member of the U.S. National Academy of Sciences in 2004.

2007

In 2007, his laboratory determined the atomic structure of the whole ribosome in complex with its tRNA and mRNA ligands.

In 2007, Ramakrishnan was awarded the Louis-Jeantet Prize for Medicine and the Datta Lectureship and Medal of the Federation of European Biochemical Societies (FEBS).

2008

In 2008, Ramakrishnan won the Heatley Medal of the British Biochemical Society, and became a Fellow of Trinity College, Cambridge and a foreign Fellow of the Indian National Science Academy.

2009

He shared the 2009 Nobel Prize in Chemistry with Thomas A. Steitz and Ada Yonath for research on the structure and function of ribosomes.

Ramakrishnan was awarded the Nobel Prize in Chemistry in 2009, along with Thomas A. Steitz and Ada Yonath.

2010

He received India's second highest civilian honor, the Padma Vibhushan, in 2010.

He has been a member of the German Academy of Sciences Leopoldina and an Honorary Fellow of the Academy of Medical Sciences (Hon FMedSci) since 2010.

He has received honorary degrees from the Maharaja Sayajirao University of Baroda, University of Utah and University of Cambridge.

He is also an Honorary Fellow of Trinity College, Cambridge, Somerville College, Oxford, and The Queen's College, Oxford.

2012

Ramakrishnan was knighted in the 2012 New Year Honours for services to molecular biology, but does not generally use the title "Sir".

That same year, he was awarded the Sir Hans Krebs Medal by the FEBS.

2013

Since 2013, he has used Cryogenic electron microscopy to work primarily on eukaryotic and mitochondrial translation.

Ramakrishnan is also known for his past work on histone and chromatin structure.

his most cited papers (according to Google Scholar ) have been published in Nature, Science, and Cell.

2015

He served as President of the Royal Society from 2015 to 2020.

Ramakrishnan's term as president of the Royal Society from 2015-2020 was dominated by Brexit and, in his final year, the COVID-19 pandemic and its response.

2018

In an interview in July 2018, he said that Britain's decision to leave the European Union was hurting Britain's reputation as a good place to work in science, commenting "It's very hard for the science community to see any advantages in Brexit. They are pretty blunt about that."

He saw advantages to both the UK and the EU for Britain to continue to be engaged in Galileo and Euratom, which, unlike the European Medicines Agency, are not EU agencies.

Ramakrishnan argued that a no-deal Brexit would harm science.

Ramakrishnan wrote, "A deal on science is in the best interests of Europe as a whole and should not be sacrificed as collateral damage over disagreements on other issues. If we are going to successfully tackle global problems like climate change, human disease and food security, we can't do so in isolation. There is no scenario where trashing our relationships with our closest scientific collaborators in the EU gets us closer to these goals."